Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography.

[1]  O. Alfieri,et al.  Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass. , 2009, Metabolism: clinical and experimental.

[2]  S. Hazen,et al.  Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk. , 2009, Journal of the American College of Cardiology.

[3]  D. Mattson,et al.  ROLE OF l‐ARGININE IN NITRIC OXIDE PRODUCTION IN HEALTH AND HYPERTENSION , 2009, Clinical and experimental pharmacology & physiology.

[4]  T. Wascher,et al.  Key role of postchallenge hyperglycemia for the presence and extent of coronary atherosclerosis: an angiographic study. , 2008, Atherosclerosis.

[5]  M. Bartoli,et al.  Diabetes-induced Coronary Vascular Dysfunction Involves Increased Arginase Activity , 2008, Circulation research.

[6]  Y. Tavil,et al.  Plasma asymmetric dimethylarginine and L-arginine levels in patients with cardiac syndrome X , 2007, Coronary artery disease.

[7]  S. Morris.  Arginine metabolism: boundaries of our knowledge. , 2007, The Journal of nutrition.

[8]  W. Durante,et al.  Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  W. Yin,et al.  L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease. , 2005, Clinical nutrition.

[10]  P. Ganz,et al.  Role of Endothelial Dysfunction in Atherosclerosis , 2004, Circulation.

[11]  J. Weil,et al.  Oral L-arginine and vitamins E and C improve endothelial function in women with type 2 diabetes , 2003, Vascular medicine.

[12]  A. Quyyumi,et al.  Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.

[13]  D. Herrington,et al.  Vascular effects of dietary L-arginine supplementation. , 2002, Atherosclerosis.

[14]  R. Nijveldt,et al.  Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. , 2002, Analytical biochemistry.

[15]  P. Stone,et al.  Randomized trial of a medical food for the dietary management of chronic, stable angina. , 2002, Journal of the American College of Cardiology.

[16]  E. Closs.  Expression, regulation and function of carrier proteins for cationic amino acids , 2002, Current opinion in nephrology and hypertension.

[17]  W. März,et al.  Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. , 2001, Pharmacogenomics.

[18]  R. Cannon,et al.  Oral L-arginine in patients with coronary artery disease on medical management. , 2000, Circulation.

[19]  J. Boucher,et al.  Effects of the new arginase inhibitor N(omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages. , 1999, Nitric oxide : biology and chemistry.

[20]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[21]  D. Celermajer,et al.  Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. , 1997, Atherosclerosis.

[22]  S. Snyder,et al.  Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Moore,et al.  Automatic recording apparatus for use in the chromatography of amino acids. , 1958, Federation proceedings.

[24]  R. Hui,et al.  Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilation is low: a meta-analysis of randomized controlled trials. , 2009, The American journal of clinical nutrition.

[25]  J. Stockman.  Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell Disease , 2007 .

[26]  M. Hayn,et al.  L-Arginine reduces lipid peroxidation in patients with diabetes mellitus. , 1997, Free radical biology & medicine.